Alkermes plc. Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal
Alkermes plc. (ALKS) reported Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal of $1.50 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Income Statement › Other Income
us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal · last filed 2026-02-25
- Alkermes plc. disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2024-12-31 was $0.00.
- Alkermes plc. disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2024-09-30 was $0.00.
- Alkermes plc. disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2015-12-31 was -$301.00K.
- Alkermes plc. disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2015-09-30 was $26.00K.
- Alkermes plc. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2024 was $1.50M.
- Alkermes plc. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2015 was $9.64M.
| Period end | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 3 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 6 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 9 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $1.50M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $1.50M 10-Q · filed 2025-10-28 | ||
| 2024-06-30 | $1.50M 10-Q · filed 2025-07-29 | |||
| 2015-12-31 | -$301.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | -$275.00K derived: sum of 2 quarters · filed 2018-02-16 | $9.64M derived: sum of 3 quarters · filed 2018-02-16 | $9.64M 10-K · filed 2018-02-16 |
| 2015-09-30 | $26.00K 10-Q · filed 2016-11-02 | $9.94M derived: sum of 2 quarters · filed 2016-11-02 | $9.94M 10-Q · filed 2016-11-02 | |
| 2015-06-30 | $9.91M 10-Q · filed 2016-07-28 | $9.91M 10-Q · filed 2016-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |